Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.

Publication

Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.

Journal Paper/Review - Apr 12, 2022

Schweizer Juliane, Arnoldini Markus, König Inke R, Bicvic Antonela, Westphal Laura Philine, Schütz Valerie, Inauen Corinne, Scherrer Natalie, Luft Andreas, Galovic Marian, Ferreira Atuesta Carolina, Pokorny Thomas, Arnold Marcel, Fischer Urs, Bonati Leo H, De Marchis Gian Marco, Kahles Timo, Nedeltchev Krassen, Cereda Carlo W, Kägi Georg, Bustamante Alejandro, Montaner Joan, Ntaios George, Sagris Dimitrios, Foerch Christian, Spanaus Katharina, von Eckardstein Arnold, Katan Mira

Citation

Schweizer J, Arnoldini M, König I, Bicvic A, Westphal L, Schütz V, Inauen C, Scherrer N, Luft A, Galovic M, Ferreira Atuesta C, Pokorny T, Arnold M, Fischer U, Bonati L, De Marchis G, Kahles T, Nedeltchev K, Cereda C, Kägi G, Bustamante A, Montaner J, Ntaios G, Sagris D, Foerch C, Spanaus K, von Eckardstein A, Katan M. Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke. J Am Coll Cardiol 2022; 79:1369-1381.

Type

Journal Paper/Review (English)

Journal

J Am Coll Cardiol 2022; 79

Publication Date

Apr 12, 2022

Issn Electronic

1558-3597

Pages

1369-1381

Brief description/objective

Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS).